The investigational treatment is currently being evaluated in a 3-part phase 1 trial (ClinicalTrials.gov Identifier: NCT05521022) in adult patients with systemic amyloidosis, as well as a phase 2 open ...

More information about Shuttle Pharma’s Phase 2 study (NCT06359379) can be found at www.clinicaltrials.gov. About Shuttle Pharmaceuticals Founded in 2012 by faculty members of the Georgetown ...

“The study is expected to be completed in the first quarter of next year according to clinicaltrials.gov and could provide ...

The sNDA was submitted to support full approval of OCA for this indication based on data from the COBALT trial, as well as real-world evidence.

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics ...

To learn more about these trials please visit ClinicalTrials.gov. This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 ...

Science has yet to prove whether ADHD can cause aphantasia, but many people report a co-occurrence. Keep reading to learn why ...

Data for the analysis were sourced from a cohort study (ClinicalTrials.gov Identifier: NCT04460157) comprising patients with and without HIV coinfection who were enrolled across 17 sites in Spain. The ...

NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...